Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Latest round
Venture round
Oct 2026 · this month
Team
201-500
employees, estimated range
Backers
1
Aisling Capital
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2 Raised a round Venture round
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2026 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity GSK plc its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene modulation therapy utilizing…
Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases…
AptimmuneSeries B $6M · 8 yr ago • 1-10 employees
True product innovation is a team-driven process that combines sound science with extensive, practical industry knowledge. To make a real…
Resilience360TM is the first enterprise software designed to future proof 1 billion assets and people ahead of disaster by 2030.
Immunogenicity intelligence, grounded in human biology.. — Problem.

Overview

At GSK, we unite science, technology and talent to get ahead of disease together.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London United Kingdom
HQ
Codes, standards and reports
200-500 est. staff
Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG
company site

Financials

Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 — Details